Related Experiment Videos

Molecular genetics and pathophysiology of Menkes disease

H Kodama1, Y Murata

  • 1Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan. hkodama@med.teikyo-u.ac.jp

Insights

Menkes disease results from mutations in the copper-transporting ATPase gene, disrupting cellular copper transport. Treatment aims to deliver copper to cuproenzymes for proper function.

Area of Science:

  • Molecular Genetics
  • Pathophysiology
  • Biochemistry

Background:

  • Menkes disease is a rare genetic disorder affecting copper transport.
  • The Menkes gene (MNK) encodes a copper-transporting ATPase.
  • Mutations in MNK lead to cellular copper deficiency and related pathologies.

Purpose of the Study:

  • To review the molecular genetics and pathophysiology of Menkes disease.
  • To discuss the role of the Menkes gene and its mutations.
  • To explore an animal model for Menkes disease.

Main Methods:

  • Review of existing literature on Menkes disease genetics and pathophysiology.
  • Analysis of Menkes gene sequencing data.
  • Examination of studies on the mottled mouse model.

Main Results:

  • The Menkes gene, located on chromosome X13.3, encodes a copper-transporting ATPase.
  • Diverse mutations (missense, nonsense, deletion, insertion) in the Menkes gene cause Menkes disease and allelic variants like occipital horn syndrome.
  • The murine mottled gene is homologous to the Menkes gene, and mutations cause similar abnormalities in mice.
  • Affected cells exhibit copper accumulation in the cytosol and impaired copper transport to organelles.
  • Cuproenzymes are deprived of essential copper, leading to dysfunction.

Conclusions:

  • Menkes disease and occipital horn syndrome are allelic variants caused by Menkes gene mutations.
  • The mottled mouse model accurately reflects Menkes disease pathophysiology.
  • Therapeutic strategies should focus on delivering copper to intracellular compartments for cuproenzyme synthesis.

Related Concept Videos